Skip to main content
Journal cover image

Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).

Publication ,  Journal Article
Talal, AH; Markatou, M; Sofikitou, EM; Brown, LS; Perumalswami, P; Dinani, A; Tobin, JN
Published in: Contemp Clin Trials
January 2022

BACKGROUND: Telemedicine has the potential to increase healthcare access especially for vulnerable populations. Telemedicine for Evaluation, Adherence, and Medication for Hepatitis C (TEAM-C) is comparing telemedicine access to specialty medical care to usual care for management of hepatitis C virus (HCV) infection among persons with opioid use disorder (PWOUD). PWOUD have the highest hepatitis C virus (HCV) prevalence and incidence, yet they infrequently receive HCV care. The study objectives are to compare access to specialty care via telemedicine to offsite specialty referral (usual care) on 1) treatment initiation, completion, and sustained virological response, 2) patient satisfaction with health care delivery, and 3) HCV reinfection after successful HCV cure. METHODS: TEAM-C is a multi-site, non-blinded, randomized pragmatic clinical trial conducted at 12 opioid treatment programs (OTP) throughout New York State that utilizes the stepped-wedge design. The unit of randomization is the OTP with a total sample size of 624 participants. HCV-infected PWOUD were treated via telemedicine or referral. Telemedicine encounters are conducted onsite in the OTP with co-administration of direct acting antivirals for HCV with medications for opioid use disorder. The primary outcome is undetectable HCV RNA obtained 12 weeks post-treatment cessation. We also follow participants for two years to assess for reinfection. CONCLUSIONS: The study utilizes a rigorous study design to evaluate the effectiveness and implementation of virtual treatment for HCV integrated into behavioral treatment. We demonstrate the feasibility, engagement principles and lessons learned from the initial prospective randomized trial of telemedicine targeted to a vulnerable population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

January 2022

Volume

112

Start / End Page

106632

Location

United States

Related Subject Headings

  • Telemedicine
  • Public Health
  • Prospective Studies
  • Patient-Centered Care
  • Opioid-Related Disorders
  • Opiate Substitution Treatment
  • Humans
  • Hepatitis C, Chronic
  • Hepatitis C
  • Hepacivirus
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Talal, A. H., Markatou, M., Sofikitou, E. M., Brown, L. S., Perumalswami, P., Dinani, A., & Tobin, J. N. (2022). Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). Contemp Clin Trials, 112, 106632. https://doi.org/10.1016/j.cct.2021.106632
Talal, Andrew H., Marianthi Markatou, Elisavet M. Sofikitou, Lawrence S. Brown, Ponni Perumalswami, Amreen Dinani, and Jonathan N. Tobin. “Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).Contemp Clin Trials 112 (January 2022): 106632. https://doi.org/10.1016/j.cct.2021.106632.
Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, et al. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). Contemp Clin Trials. 2022 Jan;112:106632.
Talal, Andrew H., et al. “Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).Contemp Clin Trials, vol. 112, Jan. 2022, p. 106632. Pubmed, doi:10.1016/j.cct.2021.106632.
Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, Tobin JN. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). Contemp Clin Trials. 2022 Jan;112:106632.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

January 2022

Volume

112

Start / End Page

106632

Location

United States

Related Subject Headings

  • Telemedicine
  • Public Health
  • Prospective Studies
  • Patient-Centered Care
  • Opioid-Related Disorders
  • Opiate Substitution Treatment
  • Humans
  • Hepatitis C, Chronic
  • Hepatitis C
  • Hepacivirus